These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8733391)

  • 1. A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses.
    Bourke JF; Berth-Jones J; Holder J; Graham-Brown RA
    Br J Dermatol; 1996 Apr; 134(4):777-9. PubMed ID: 8733391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoral (cyclosporin) in dermatology: technical aspects.
    Smith SG
    Br J Dermatol; 1996 Sep; 135 Suppl 48():2-4. PubMed ID: 8881896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin.
    Gulliver WP; Murphy GF; Hannaford VA; Primmett DR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():35-9. PubMed ID: 8881903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects: preliminary experience with a novel oral formulation of cyclosporin (Neoral).
    Berth-Jones J
    Br J Dermatol; 1996 Sep; 135 Suppl 48():5-8. PubMed ID: 8881897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the steady state pharmacokinetics of two formulations of cyclosporin in patients with atopic dermatitis.
    Chawla M; Ali M; Marks R
    Br J Dermatol; 1996 Sep; 135 Suppl 48():9-14. PubMed ID: 8881898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
    Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.
    Koo J
    Br J Dermatol; 1998 Jul; 139(1):88-95. PubMed ID: 9764154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
    Zurbriggen B; Wüthrich B; Cachelin AB; Wili PB; Kägi MK
    Dermatology; 1999; 198(1):56-60. PubMed ID: 10026403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
    Yocum DE; Allard S; Cohen SB; Emery P; Flipo RM; Goobar J; Jayawardena S; Job-Deslandre C; Jubb RW; Krüger K; Lopes Vaz A; Manger B; Mur E; Nygaard H; Weiner SM; Rainer F; Sack MR; Schiff MH; Schnitzer TJ; Trigg LB; Whatmough I; Schmidt AG
    Rheumatology (Oxford); 2000 Feb; 39(2):156-64. PubMed ID: 10725065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe atopic dermatitis in childhood with cyclosporin.
    Zaki I; Emerson R; Allen BR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():21-4. PubMed ID: 8881900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
    Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoral--new cyclosporin for old?
    Somerville MF; Scott DG
    Br J Rheumatol; 1997 Oct; 36(10):1113-5. PubMed ID: 9374930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
    Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA
    G Ital Dermatol Venereol; 2016 Aug; 151(4):432-5. PubMed ID: 25786483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin in childhood psoriasis.
    Perrett CM; Ilchyshyn A; Berth-Jones J
    J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996.
    Berth-Jones J; Voorhees JJ
    Br J Dermatol; 1996 Nov; 135(5):775-7. PubMed ID: 8977680
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.
    Trull AK; Tan KK; Tan L; Alexander GJ; Jamieson NV
    Br J Clin Pharmacol; 1995 Jun; 39(6):627-31. PubMed ID: 7654480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin for atopic dermatitis in children.
    Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
    Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.